Results
Mankind Pharma Q4 FY26 Revenue Up 11.8% YoY
Mankind Pharma reported Q4 FY26 revenue growth of 11.8% YoY to ₹3,443 crore with adjusted EBITDA margin expanding 400 bps to 27.1%.
Domestic revenue excluding Consumer Healthcare grew 12.9% in Q4, dri
